FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Walter Haefeli

Research Profile

Physiology

Geographic Areas

Germany

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Vasodilation

Co-author Network

Publications

TOP 3
B Halama; N Hohmann; Gerd Mikus; J Weiss; Jürgen Burhenne; Walter E Haefeli
A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions.
V C Ziesenitz; J Weiss; Walter E Haefeli; Gerd Mikus
Cytochrome P450-3A Phenotyping Using Midazolam Is Not Altered by OATP1B1 Polymorphisms.
Julia T Schiele; Hans-Dieter Klimm; Markus Pruszydlo; Renate Quinzler; Walter E Haefeli
Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Walter Haefeli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: B Halama; N Hohmann; Gerd Mikus; J Weiss; Jürgen Burhenne; Walter E Haefeli
A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions.
Clinical pharmacology and therapeutics 2013;93(6):564-71.
2013: V C Ziesenitz; J Weiss; Walter E Haefeli; Gerd Mikus
Cytochrome P450-3A Phenotyping Using Midazolam Is Not Altered by OATP1B1 Polymorphisms.
Clinical pharmacology and therapeutics 2013;93(5):388.
2013: Julia T Schiele; Hans-Dieter Klimm; Markus Pruszydlo; Renate Quinzler; Walter E Haefeli
Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms.
European journal of clinical pharmacology 2013;69(4):937-48.
2013: Nadine C L Zembruski; Ramadan M M Ali; Jürgen Burhenne; Walter E Haefeli; Udo Heintz; Melanie Herzog; Götz Hofhaus; Chi D L Nguyen; Dirk Theile; Johanna Weiss
Liposomal sphingomyelin influences the cellular lipid profile of human lymphoblastic leukemia cells without effect on P-glycoprotein activity.
Molecular pharmaceutics 2013;10(3):1020-34.
2013: Antje Blank; Lars L Gustafsson; Jens Kaltschmidt; Andreas Krings; Svetla Loukanova; Nathan Mensah; Helen Prytherch; Rainer Sauerborn; Felix Sukums; Alphonse Zakane; Walter E Haefeli
"Quality of prenatal and maternal care: bridging the know-do gap" (QUALMAT study): an electronic clinical decision support system for rural Sub-Saharan Africa.
BMC medical informatics and decision making 2013;13():44.
2013: Diana Witticke; Kristina Lohmann; Hanna M Seidling; Alexander F J Send; Walter E Haefeli
Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in Germany.
Drug safety : an international journal of medical toxicology and drug experience 2013;36(1):31-41.
2012: Nadine C L Zembruski; Walter E Haefeli; Vanessa Stache; Johanna Weiss
7-Aminoactinomycin D for apoptosis staining in flow cytometry.
Analytical biochemistry 2012;429(1):79-81.
2012: Florentine Carow; Hans H Maurer; Markus R Meyer; Frank T Peters; Karin Rieger; Ingeborg Walter-Sack; Walter E Haefeli
Objective assessment of nonadherence and unknown co-medication in hospitalized patients.
European journal of clinical pharmacology 2012;68(8):1191-9.
2012: Anja Keubler; Gerd Mikus; Johanna Weiss; Walter E Haefeli; Jürgen Burhenne
Drug interaction of efavirenz and midazolam: efavirenz activates the CYP3A-mediated midazolam 1'-hydroxylation in vitro.
Drug metabolism and disposition: the biological fate of chemicals 2012;40(6):1178-82.
2012: Ramadan Ali; Benito Campos; Gerhard Dyckhoff; Walter E Haefeli; Christel Herold-Mende; Jürgen Burhenne
Quantification of retinoid concentrations in human serum and brain tumor tissues.
Analytica chimica acta 2012;725():57-66.
2012: Dirk Theile; Johanna Weiss; Jan-Christoph Detering; Gerhard Dyckhoff; Walter E Haefeli; Christel Herold-Mende; Jürgen Burhenne
Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometry.
The Journal of pharmacology and experimental therapeutics 2012;341(1):51-8.
2012: Jürgen Burhenne; Birte Halama; Nicolas Hohmann; Monika Maurer; Gerd Mikus; Klaus-Dieter Riedel; Walter E Haefeli
Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.
Analytical and bioanalytical chemistry 2012;402(7):2439-50.
2012: Thilo Bertsche; Jonas Fiederling; Jens Kaltschmidt; Markus Nachbar; Simon P W Schmitt; Hanna M Seidling; Walter E Haefeli
Assessment of a computerised decision support system for allergic rhino-conjunctivitis counselling in German pharmacy.
International journal of clinical pharmacy 2012;34(1):17-22.
2012: Markus Pruszydlo; Stefanie U Walk-Fritz; Torsten Hoppe-Tichy; Jens Kaltschmidt; Walter E Haefeli
Development and evaluation of a computerised clinical decision support system for switching drugs at the interface between primary and tertiary care.
BMC medical informatics and decision making 2012;12():137.
2012: Antje Erler; Martin Beyer; Walter E Haefeli; Juliana J Petersen; Thomas Rath; Justine Rochon; Kristina Saal; Ferdinand M Gerlach
How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial.
BMC family practice 2012;13():91.
2012: Andreas G Niethammer; Marco Springer; Jürgen Weitz; Mustafa Akhisaroglu; Philipp Beckhove; Markus W Buchler; Yingzi Ge; Lars Grenacher; Walter E Haefeli; Nicolas Hohmann; Philipp Knebel; Moritz Koch; Christine Leowardi; Heinz Lubenau; Gerd Mikus; Friedrich H Schmitz-Winnenthal
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.
BMC cancer 2012;12():361.
2012: Simon Maxwell; Anna Bucsics; Hans-Georg Eichler; Lars L Gustafsson; Walter E Haefeli
e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers.
British journal of clinical pharmacology 2012;73(1):12-5.
2011: H Ardeschir Ghofrani; Matthias Gorenflo; Ekkehard Grünig; Walter E Haefeli; Matthias Held; Marius M Hoeper; Harald Kaemmerer; Christian M Kähler; Hans Klose; Volker Köllner; Bruno Kopp; Siegrun Mebus; Andreas Meyer; O Miera; David Pittrow; Gabriela Riemekasten; Stephan Rosenkranz; Dietmar Schranz; Robert Voswinckel; Oliver Distler; Felix Gerhardt; Horst Olschewski
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011.
International journal of cardiology 2011;154 Suppl 1():S20-33.
2011: Christine Eichbaum; Walter E Haefeli
[Biologics - nomenclature and classification].
Therapeutische Umschau. Revue thérapeutique 2011;68(11):593-601.
2011: Cornelia Mahler; Markus Pruszydlo; Thilo Bertsche; H Gärtner; Walter E Haefeli; K Hermann; S Jank; J Kaltschmidt; Sabine Ludt; Joachim Szecsenyi
[HeiCare®: a project aiming to improve medication communication across health care sectors].
Deutsche medizinische Wochenschrift (1946) 2011;136(44):2239-44.
2011: S Katzenmaier; C Markert; Jürgen Burhenne; Walter E Haefeli; Klaus-Dieter Riedel; Gerd Mikus
Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy.
Clinical pharmacology and therapeutics 2011;90(5):666-73.
2011: Hanna M Seidling; Shimon Shaykevich; Walter E Haefeli; Marilyn D Paterno; Shobha Phansalkar; Diane L Seger; David W Bates
Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support.
Journal of the American Medical Informatics Association : JAMIA 2011;18(4):479-84.
2011: Reinhard Ding; Eva Frei; Mahmoudreza Fardanesh; Hans-Hermann Schrenk; Paul Kremer; Walter E Haefeli
Pharmacokinetics of 5-aminofluorescein-albumin, a novel fluorescence marker of brain tumors during surgery.
Journal of clinical pharmacology 2011;51(5):672-8.
2011: Jun Yin; Marian Kukucka; Julia Hoffmann; Anja Sterner-Kock; Juergen Burhenne; Walter E Haefeli; Hermann Kuppe; Wolfgang M Kuebler
Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Circulation. Heart failure 2011;4(2):198-206.
2011: Arwa Hassan; Jürgen Burhenne; Klaus-Dieter Riedel; Johanna Weiss; Gerd Mikus; Walter E Haefeli; David Czock
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.
Therapeutic drug monitoring 2011;33(1):86-93.
2011: C Senger; H M Seidling; Renate Quinzler; U Leser; Walter E Haefeli
Design and evaluation of an ontology-based drug application database.
Methods of information in medicine 2011;50(3):273-84.
2011: Melanie Herzog; Caroline Henrike Storch; Philipp Gut; Dimitry Kotlyar; Joachim Füllekrug; Robert Ehehalt; Walter E Haefeli; Johanna Weiss
Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity.
Naunyn-Schmiedeberg's archives of pharmacology 2011;383(1):1-11.
2010: Christian Senger; Jens Kaltschmidt; Simon P W Schmitt; Markus Pruszydlo; Walter E Haefeli
Misspellings in drug information system queries: characteristics of drug name spelling errors and strategies for their prevention.
International journal of medical informatics 2010;79(12):832-9.
2010: Kristina Zint; Walter E Haefeli; Robert J Glynn; Helen Mogun; Jerry Avorn; Til Stuermer
Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults.
Pharmacoepidemiology and drug safety 2010;19(12):1248-55.
2010: Hanna M Seidling; Marilyn D Paterno; Walter E Haefeli; David W Bates
Coded entry versus free-text and alert overrides: what you get depends on how you ask.
International journal of medical informatics 2010;79(11):792-6.
2010: Thilo Bertsche; Carolin Veith; Alexander Stahl; Torsten Hoppe-Tichy; F Joachim Meyer; Hugo A Katus; Walter E Haefeli
A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilities.
Pharmacy world & science : PWS 2010;32(5):663-9.
2010: H M Seidling; S P W Schmitt; T Bruckner; J Kaltschmidt; Markus Pruszydlo; C Senger; Thilo Bertsche; Ingeborg Walter-Sack; Walter E Haefeli
Patient-specific electronic decision support reduces prescription of excessive doses.
Quality & safety in health care 2010;19(5):e15.
2010: Verena Hafner; David Czock; Jürgen Burhenne; Klaus-Dieter Riedel; Jürgen Bommer; Gerd Mikus; Christoph Machleidt; T Weinreich; Walter E Haefeli
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
Antimicrobial agents and chemotherapy 2010;54(6):2596-602.
2010: Thilo Bertsche; Johannes Pfaff; Petra Schiller; Jens Kaltschmidt; Markus G Pruszydlo; Wolfgang Stremmel; Ingeborg Walter-Sack; Walter E Haefeli; Jens Encke
Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system.
Intensive care medicine 2010;36(4):665-72.
2010: Arwa Hassan; Walter E Haefeli
Appropriateness of timing of drug administration in electronic prescriptions.
Pharmacy world & science : PWS 2010;32(2):162-71.
2010: Johanna Weiss; A Sauer; N Divac; M Herzog; E Schwedhelm; Rainer H Böger; Walter E Haefeli; R A Benndorf
Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Biopharmaceutics & drug disposition 2010;31(2-3):150-61.
2010: V Hafner; B Grün; C Markert; David Czock; Gerd Mikus; Walter E Haefeli
[Drug interactions].
Der Internist 2010;51(3):359-69; quiz 370.
2010: V Hafner; M Jäger; A-K Matthée; Reinhard Ding; Jürgen Burhenne; Walter E Haefeli; Gerd Mikus
Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity.
Clinical pharmacology and therapeutics 2010;87(2):191-6.
2009: Thilo Bertsche; Vasileios Askoxylakis; Gregor Habl; Friederike Laidig; Jens Kaltschmidt; Simon P W Schmitt; Hamid Ghaderi; Angelika Zabel-du Bois; Stefanie Milker-Zabel; Jürgen Debus; Hubert J Bardenheuer; Walter E Haefeli
Multidisciplinary pain management based on a computerized clinical decision support system in cancer pain patients.
Pain 2009;147(1-3):20-8.
2009: Ina Scholz; Heike Oberwittler; Klaus-Dieter Riedel; Jürgen Burhenne; Johanna Weiss; Walter E Haefeli; Gerd Mikus
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.
British journal of clinical pharmacology 2009;68(6):906-15.
2009: Dirk Theile; Sina Grebhardt; Walter E Haefeli; Johanna Weiss
Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.
Biochemical pharmacology 2009;78(11):1366-73.
2009: David Czock; Thilo Bertsche; Walter E Haefeli
Drug dose adjustments in patients with renal impairment.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(5):983-4; author reply 985-6.
2009: Cornelia Mahler; Susanne Jank; Katja Hermann; Rob Horne; Sabine Ludt; Walter E Haefeli; Joachim Szecsenyi
Psychometric properties of a German version of the "Satisfaction with Information about Medicines Scale" (SIMS-D).
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(8):1176-9.
2009: Hanna Marita Seidling; Caroline Henrike Storch; Thilo Bertsche; Christian Senger; Jens Kaltschmidt; Ingeborg Walter-Sack; Walter E Haefeli
Successful strategy to improve the specificity of electronic statin-drug interaction alerts.
European journal of clinical pharmacology 2009;65(11):1149-57.
2009: Cornelia Mahler; S Jank; K Hermann; Walter E Haefeli; Joachim Szecsenyi
[Information on medications - How do chronically ill patients assess counselling on drugs in general practice?].
Deutsche medizinische Wochenschrift (1946) 2009;134(33):1620-4.
2009: Arwa Benkhaial; Jens Kaltschmidt; Elke Weisshaar; Thomas L Diepgen; Walter E Haefeli
Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes.
Pharmacy world & science : PWS 2009;31(4):464-72.
2009: Susanne Jank; Thilo Bertsche; Dieter Schellberg; Wolfgang Herzog; Walter E Haefeli
The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers.
Pharmacy world & science : PWS 2009;31(4):426-31.
2009: Thilo Bertsche; Martina Fleischer; Johannes Pfaff; Jens Encke; David Czock; Walter E Haefeli
Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency.
European journal of clinical pharmacology 2009;65(8):823-9.
2009: Antje Blank; Victoria Hellstern; Dieter Schuster; Martin Hartmann; Anne K Matthée; Jürgen Burhenne; Walter E Haefeli; Gerd Mikus
Efavirenz treatment and false-positive results in benzodiazepine screening tests.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(12):1787-9.
2009: Thilo Bertsche; J Kaltschmidt; Walter E Haefeli
[Patient safety based on computer-assisted drug therapy. Electronic check-up of the patient].
Der Internist 2009;50(6):748-56.
2009: Johanna Weiss; Magdalena Maria Ten Hoevel; Jürgen Burhenne; Ingeborg Walter-Sack; Michael M Hoffmann; Jens Rengelshausen; Walter E Haefeli; Gerd Mikus
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.
Journal of clinical pharmacology 2009;49(2):196-204.
2009: Johanna Weiss; Alexandra Sauer; Melanie Herzog; Rainer H Böger; Walter E Haefeli; Ralf A Benndorf
Interaction of thiazolidinediones (glitazones) with the ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein.
Pharmacology 2009;84(5):264-70.
2009: Renate Quinzler; Simon Schmitt; Maria Pritsch; Jens Kaltschmidt; Walter E Haefeli
Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm.
BMC medical informatics and decision making 2009;9():30.
2008: Thilo Bertsche; Dorothee Niemann; Yvonne Mayer; Katrin Ingram; Torsten Hoppe-Tichy; Walter E Haefeli
Prioritising the prevention of medication handling errors.
Pharmacy world & science : PWS 2008;30(6):907-15.
2008: Verena Hafner; Nadine Albermann; Walter E Haefeli; Friedrich Ebinger
Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis.
Antimicrobial agents and chemotherapy 2008;52(11):4172-4.
2008: Walter E Haefeli; Ingeborg Walter-Sack
[Particularities of drug dosing at the beginning and end of therapy].
Therapeutische Umschau. Revue thérapeutique 2008;65(10):573-5.
2008: Jürgen Burhenne; Walter E Haefeli; Michael Hess; Alexandra Scope
Pharmacokinetics, tissue concentrations, and safety of the antifungal agent voriconazole in chickens.
Journal of avian medicine and surgery 2008;22(3):199-207.
2008: Johanna Weiss; Evelyn Sawa; Klaus-Dieter Riedel; Walter E Haefeli; Gerd Mikus
In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6.
Naunyn-Schmiedeberg's archives of pharmacology 2008;378(3):275-82.
2008: Renate Quinzler; Thilo Bertsche; Joachim Szecsenyi; Walter E Haefeli
[Tablet splitting: do discount contracts influence prescribing quality?].
Medizinische Klinik (Munich, Germany : 1983) 2008;103(8):569-74.
2008: Markus Pruszydlo; Renate Quinzler; J Kaltschmidt; Walter E Haefeli
[Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
Deutsche medizinische Wochenschrift (1946) 2008;133(27):1423-8.
2008: Caroline Henrike Storch; Christoph Nikendei; Sandra Schild; Walter E Haefeli; Johanna Weiss; Wolfgang Herzog
Expression and activity of P-glycoprotein (MDR1/ABCB1) in peripheral blood mononuclear cells from patients with anorexia nervosa compared with healthy controls.
The International journal of eating disorders 2008;41(5):432-8.
2008: S Jank; Thilo Bertsche; Wolfgang Herzog; Walter E Haefeli
Patient knowledge on oral anticoagulants: results of a questionnaire survey in Germany and comparison with the literature.
International journal of clinical pharmacology and therapeutics 2008;46(6):280-8.
2008: Felix Gut; Wolfgang Schiek; Walter E Haefeli; Ingeborg Walter-Sack; Jürgen Burhenne
Cation exchange resins as pharmaceutical carriers for methylene blue: binding and release.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(2):582-7.
2008: K Pfeiffer; F Some; Olaf Müller; A Sie; Bocar Kouyaté; Walter E Haefeli; A Zoungrana; Lars ´Gustafsson; G Tomson; Rainer Sauerborn
Clinical diagnosis of malaria and the risk of chloroquine self-medication in rural health centres in Burkina Faso.
Tropical medicine & international health : TM & IH 2008;13(3):418-26.
2008: Jürgen Burhenne; Klaus-Dieter Riedel; Jens Rengelshausen; Peter E Meissner; Olaf Müller; Gerd Mikus; Walter E Haefeli; Ingeborg Walter-Sack
Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;863(2):273-82.
2008: Jens Kaltschmidt; Simon Schmitt; Markus Pruszydlo; Walter E Haefeli
Characteristics of effective electronic mail messages distributed to healthcare professionals in a hospital setting.
Journal of the American Medical Informatics Association : JAMIA 2008;15(2):235-9.
2008: Stefanie U Walk; Thilo Bertsche; Jens Kaltschmidt; Markus Pruszydlo; Torsten Hoppe-Tichy; Ingeborg Walter-Sack I; Walter E Haefeli
Rule-based standardised switching of drugs at the interface between primary and tertiary care.
European journal of clinical pharmacology 2008;64(3):319-27.
2008: Johanna Weiss; Nicola Weis; Nahal Ketabi-Kiyanvash; Caroline Henrike Storch; Walter E Haefeli
Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors.
European journal of pharmacology 2008;579(1-3):104-9.
2007: Renate Quinzler; Joachim Szecsenyi; Walter E Haefeli
Tablet splitting: patients and physicians need better support.
European journal of clinical pharmacology 2007;63(12):1203-4.
2007: H M Seidling; A Al Barmawi; J Kaltschmidt; T Bertsche; Markus Pruszydlo; Walter E Haefeli
Detection and prevention of prescriptions with excessive doses in electronic prescribing systems.
European journal of clinical pharmacology 2007;63(12):1185-92.
2007: Caroline Henrike Storch; Hans-Dieter Klimm; Tilman Heinrich; Walter E Haefeli; Johanna Weiss
Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells.
Naunyn-Schmiedeberg's archives of pharmacology 2007;376(1-2):135-43.
2007: Caroline Henrike Storch; Robert Ehehalt; Walter E Haefeli; Johanna Weiss
Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro.
The Journal of pharmacology and experimental therapeutics 2007;323(1):257-64.
2007: Renate Quinzler; Simon Schmitt; Joachim Szecsenyi; Walter E Haefeli
Optimizing information on drug exposure by collection of package code information in questionnaire surveys.
Pharmacoepidemiology and drug safety 2007;16(9):1024-30.
2007: Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid.
International journal of clinical pharmacology and therapeutics 2007;45(8):431-7.
2007: Caroline Henrike Storch; Dirk Theile; Heike Lindenmaier; Walter E Haefeli; Johanna Weiss
Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein.
Biochemical pharmacology 2007;73(10):1573-81.
2007: F Josephson; Annika Allqvist; M Janabi; Jane Sayi; Eleni Aklillu; Mary Jande; Margarita Mahindi; J Burhenne; Y Bottiger; Lars ´Gustafsson; Walter E Haefeli; Leif Bertilsson
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir.
Clinical pharmacology and therapeutics 2007;81(5):708-12.
2007: Manuela Ehrhardt; Marion Möck; Walter E Haefeli; Gerd Mikus; Jürgen Burhenne
Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;850(1-2):249-58.
2007: Nahal Ketabi-Kiyanvash; Christel Herold-Mende; Farzaneh Kashfi; Sandra Caldeira; Massimo Tommasino; Walter E Haefeli; Johanna Weiss
NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics.
Cell and tissue research 2007;328(1):19-29.
2007: Jörg Indermitte; Laura Erba; Marianne Beutler; Rudolf Bruppacher; Walter E Haefeli; Kurt E Hersberger
Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland.
European journal of clinical pharmacology 2007;63(3):297-305.
2007: Johanna Weiss; Dirk Theile; Nahal Ketabi-Kiyanvash; Heike Lindenmaier; Walter E Haefeli
Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.
Drug metabolism and disposition: the biological fate of chemicals 2007;35(3):340-4.
2007: Johanna Weiss; Johanna Rose; Caroline Henrike Storch; Nahal Ketabi-Kiyanvash; Alexandra Sauer; Walter E Haefeli; Thomas Efferth
Modulation of human BCRP (ABCG2) activity by anti-HIV drugs.
The Journal of antimicrobial chemotherapy 2007;59(2):238-45.
2007: Anne-Kathrin Gehrig; Gerd Mikus; Walter E Haefeli; Jürgen Burhenne
Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma.
Rapid communications in mass spectrometry : RCM 2007;21(16):2704-16.
2007: Heike Oberwittler; Andreas Hirschfeld-Warneken; Roland Wesch; Hans Willerich; Lenore Teichert; Karl-Heinz Lehr; Reinhard Ding; Walter E Haefeli; Gerd Mikus
Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
Journal of clinical pharmacology 2007;47(1):70-7.
2007: Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Antimicrobial agents and chemotherapy 2007;51(1):239-44.
2006: Renate Quinzler; Christiane Gasse; Antonius Schneider; Petra Kaufmann-Kolle; Joachim Szecsenyi; Walter E Haefeli
The frequency of inappropriate tablet splitting in primary care.
European journal of clinical pharmacology 2006;62(12):1065-73.
2006: Jens Rengelshausen; Bernd Beedgen; Konstantina Tsamouranis; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli; Otwin Linderkamp
Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.
European journal of clinical pharmacology 2006;62(9):773-7.
2006: Gerd Mikus; Verena Schöwel; Magdalena Drzewinska; Jens Rengelshausen; Reinhard Ding; Klaus-Dieter Riedel; Jürgen Burhenne; Johanna Weiss; Torben Thomsen; Walter E Haefeli
Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
Clinical pharmacology and therapeutics 2006;80(2):126-35.
2006: Thilo Bertsche; Reiner Fritz; Peter Sauer; Jens Encke; Walter E Haefeli; Ingeborg Walter-Sack
[Off label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
Medizinische Monatsschrift für Pharmazeuten 2006;29(7):257-62.
2006: R Quinzler; Walter E Haefeli
[Tablet splitting].
Therapeutische Umschau. Revue thérapeutique 2006;63(6):441-7.
2006: Walter E Haefeli
[Drug administration errors--what information is required to enable patients to safely take their drugs?].
Therapeutische Umschau. Revue thérapeutique 2006;63(6):363-5.
2006: Thilo Bertsche; M Haas; H Oberwittler; Walter E Haefeli; Ingeborg Walter-Sack
[Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model].
Deutsche medizinische Wochenschrift (1946) 2006;131(18):1016-22.
2006: Christiane Hesse; Steffen P Luntz; Heike Siedler; Kristina Unnebrink; Gerd Mikus; Marianne de Bruijn; Edu Zondag; Michiel de Vries; Monika Seibert-Grafe; Walter E Haefeli
Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individuals.
British journal of clinical pharmacology 2006;61(4):414-9.
2006: Raoul Bergner; Martin Hoffmann; Klaus-Dieter Riedel; Gerd Mikus; Dirk M Henrich; Walter E Haefeli; Michael Uppenkamp; Ingeborg Walter-Sack
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):1019-23.
2006: Johanna Weiss; Walter E Haefeli
Evaluation of inhibitory potencies for compounds inhibiting P-glycoprotein but without maximum effects: f2 values.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(2):203-7.
2006: Petra Knaup; Jochen Pilz; J Kaltschmidt; Sabine Ludt; Joachim Szecsenyi; Walter E Haefeli
Standardized documentation of drug recommendations in discharge letters--a contribution to quality management in cooperative care.
Methods of information in medicine 2006;45(4):336-42.
2006: Tanja Peters; Heike Lindenmaier; Walter E Haefeli; Johanna Weiss
Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
Naunyn-Schmiedeberg's archives of pharmacology 2006;372(4):291-9.
2006: Florian Hartge; Thomas Wetter; Walter E Haefeli
A similarity measure for case based reasoning modeling with temporal abstraction based on cross-correlation.
Computer methods and programs in biomedicine 2006;81(1):41-8.
2005: Thilo Bertsche; Reiner Fritz; Peter Sauer; Jens Encke; Walter E Haefeli; Ingeborg Walter-Sack
[Off-label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
Medizinische Klinik (Munich, Germany : 1983) 2005;100(12):820-4.
2005: Christiane Hesse; Heike Siedler; Jürgen Burhenne; Klaus-Dieter Riedel; Walter E Haefeli
Fluvoxamine affects sildenafil kinetics and dynamics.
Journal of clinical psychopharmacology 2005;25(6):589-92.
2005: Christiane Hesse; Heike Siedler; Steffen P Luntz; Bianca M Arendt; Roland Goerlich; Ruth Fricker; Martina Heer; Walter E Haefeli
Modulation of endothelial and smooth muscle function by bed rest and hypoenergetic, low-fat nutrition.
Journal of applied physiology (Bethesda, Md. : 1985) 2005;99(6):2196-203.
2005: Holger Borwitzky; Walter E Haefeli; Jürgen Burhenne
Analysis of methylene blue in human urine by capillary electrophoresis.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;826(1-2):244-51.
2005: Monique Akoachere; Kathrin Buchholz; Elisabeth Fischer; Jürgen Burhenne; Walter E Haefeli; R Heiner Schirmer; Katja Becker
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins.
Antimicrobial agents and chemotherapy 2005;49(11):4592-7.
2005: Heike Lindenmaier; Melanie Becker; Walter E Haefeli; Johanna Weiss
Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2).
Drug metabolism and disposition: the biological fate of chemicals 2005;33(11):1576-9.
2005: Nadine Albermann; Friedrich H Schmitz-Winnenthal; Kaspar Z'graggen; Christine Volk; Michael M Hoffmann; Walter E Haefeli; Johanna Weiss
Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Biochemical pharmacology 2005;70(6):949-58.
2005: Marc Moritz Berger; Christiane Hesse; Christoph Dehnert; Heike Siedler; Petra Kleinbongard; Hubert J Bardenheuer; Malte Kelm; Peter Bärtsch; Walter E Haefeli
Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema.
American journal of respiratory and critical care medicine 2005;172(6):763-7.
2005: Christiane Gasse; Jennifer Hollowell; Christoph R Meier; Walter E Haefeli
Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin.
Thrombosis and haemostasis 2005;94(3):537-43.
2005: Jens Rengelshausen; Maria Banfield; Klaus-Dieter Riedel; Jürgen Burhenne; Johanna Weiss; Torben Thomsen; Ingeborg Walter-Sack; Walter E Haefeli; Gerd Mikus
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.
Clinical pharmacology and therapeutics 2005;78(1):25-33.
2005: Verena Bergk; Walter E Haefeli; Christiane Gasse; Hermann Brenner; Meret Martin-Facklam
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature.
European journal of clinical pharmacology 2005;61(5-6):327-35.
2005: Verena Bergk; Christiane Gasse; Rainer Schnell; Walter E Haefeli
Mail surveys: obsolescent model or valuable instrument in general practice research?
Swiss medical weekly 2005;135(13-14):189-91.
2005: Michael Streit; Christoph Göggelmann; Christoph Dehnert; Jürgen Burhenne; Klaus-Dieter Riedel; Elmar Menold; Gerd Mikus; Peter Bärtsch; Walter E Haefeli
Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m).
European journal of clinical pharmacology 2005;61(1):39-46.
2005: Meret Martin-Facklam; Jens Rengelshausen; Yorki Tayrouz; Nahal Ketabi-Kiyanvash; Heike Lindenmaier; Verena Schneider; Verena Bergk; Walter E Haefeli
Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?
European journal of clinical pharmacology 2005;60(11):807-11.
2004: Klaus-Dieter Riedel; Karin Rieger; Meret Martin-Facklam; Gerd Mikus; Walter E Haefeli; Jürgen Burhenne
Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;813(1-2):27-33.
2004: Margit Fröhlich; Nadine Albermann; Alexandra Sauer; Ingeborg Walter-Sack; Walter E Haefeli; Johanna Weiss
In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins.
Biochemical pharmacology 2004;68(12):2409-16.
2004: Jens Rengelshausen; Jürgen Burhenne; Margit Fröhlich; Yorki Tayrouz; Shio Kumar Singh; Klaus-Dieter Riedel; Olaf Müller; Torsten Hoppe-Tichy; Walter E Haefeli; Gerd Mikus; Ingeborg Walter-Sack
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria.
European journal of clinical pharmacology 2004;60(10):709-15.
2004: Joachim Troost; Heike Lindenmaier; Walter E Haefeli; Johanna Weiss
Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells.
Molecular pharmacology 2004;66(5):1332-9.
2004: Silvana C Romerio; Lilly Linder; Jürg Nyfeler; Markus Wenk; Piotr Litynsky; Reto Asmis; Walter E Haefeli
Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults.
Atherosclerosis 2004;176(2):337-44.
2004: Margit Fröhlich; Michael M Hoffmann; Jürgen Burhenne; Gerd Mikus; Johanna Weiss; Walter E Haefeli
Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics.
British journal of clinical pharmacology 2004;58(4):443-4.
2004: Meret Martin-Facklam; Karin Rieger; Klaus-Dieter Riedel; Jürgen Burhenne; Ingeborg Walter-Sack; Walter E Haefeli
Undeclared exposure to St. John's Wort in hospitalized patients.
British journal of clinical pharmacology 2004;58(4):437-41.
2004: Verena Bergk; Christiane Gasse; Rainer Schnell; Walter E Haefeli
Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany.
European journal of clinical pharmacology 2004;60(8):595-602.
2004: Peter Martin; Walter E Haefeli; Meret Martin-Facklam
A drug database model as a central element for computer-supported dose adjustment within a CPOE system.
Journal of the American Medical Informatics Association : JAMIA 2004;11(5):427-32.
2004: Ruth Fricker; Christiane Hesse; Johanna Weiss; Yorki Tayrouz; Michael M Hoffmann; Kristina Unnebrink; Ulrich Mansmann; Walter E Haefeli
Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation.
British journal of clinical pharmacology 2004;58(2):169-77.
2004: Jens Rengelshausen; Heike Lindenmaier; Tomas Cihlar; Ingeborg Walter-Sack; Walter E Haefeli; Johanna Weiss
Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine.
Biochemical and biophysical research communications 2004;320(1):90-4.
2004: Verena Bergk; Christiane Gasse; Dietrich Rothenbacher; Michael Loew; Hermann Brenner; Walter E Haefeli
Drug interactions in primary care: impact of a new algorithm on risk determination.
Clinical pharmacology and therapeutics 2004;76(1):85-96.
2004: Reinhard Ding; Yorki Tayrouz; Klaus-Dieter Riedel; Jürgen Burhenne; Johanna Weiss; Gerd Mikus; Walter E Haefeli
Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers.
Clinical pharmacology and therapeutics 2004;76(1):73-84.
2004: Karin Rieger; André Scholer; Isabelle Arnet; Frank T Peters; Hans H Maurer; Ingeborg Walter-Sack; Walter E Haefeli; Meret Martin-Facklam
High prevalence of unknown co-medication in hospitalised patients.
European journal of clinical pharmacology 2004;60(5):363-8.
2004: Johanna Weiss; Walter E Haefeli
Genotyping of the A6986G polymorphism of CYP3A5.
British journal of clinical pharmacology 2004;57(5):663; author reply 664.
2004: Margit Fröhlich; Jürgen Burhenne; Meret Martin-Facklam; Johanna Weiss; Michael Von Wolff; Thomas Strowitzki; Ingeborg Walter-Sack; Walter E Haefeli
Oral contraception does not alter single dose saquinavir pharmacokinetics in women.
British journal of clinical pharmacology 2004;57(3):244-52.
2004: Sylvia Bähring; Anita Rauch; Okan Toka; Christoph Schroeder; Christiane Hesse; Heike Siedler; Gabor Fesüs; Walter E Haefeli; Andreas Busjahn; Atakan Aydin; Yvette Neuenfeld; Astrid Mühl; Hakan R Toka; Maik Gollasch; Jens Jordan; Friedrich C Luft
Autosomal-dominant hypertension with type E brachydactyly is caused by rearrangement on the short arm of chromosome 12.
Hypertension 2004;43(2):471-6.
2004: Manuela Ehrhardt; Heike Lindenmaier; Jürgen Burhenne; Walter E Haefeli; Johanna Weiss
Influence of lipid lowering fibrates on P-glycoprotein activity in vitro.
Biochemical pharmacology 2004;67(2):285-92.
2004: Gerd Mikus; Laila Schmidt; Jürgen Burhenne; Reinhard Ding; Klaus-Dieter Riedel; Yorki Tayrouz; Johanna Weiss; Walter E Haefeli
Reduction of saquinavir exposure by coadministration of loperamide: a two-way pharmacokinetic interaction.
Clinical pharmacokinetics 2004;43(14):1015-24.
2004: Meret Martin-Facklam; Michael Kostrzewa; Peter Martin; Walter E Haefeli
Quality of drug information on the World Wide Web and strategies to improve pages with poor information quality. An intervention study on pages about sildenafil.
British journal of clinical pharmacology 2004;57(1):80-5.
2003: Nahal Ketabi-Kiyanvash; Johanna Weiss; Walter E Haefeli; Gerd Mikus
P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine.
Addiction biology 2003;8(4):413-8.
2003: Verena Schneider; Volkmar Henschel; Keyvan Tadjalli Mehr; Ulrich Mansmann; Walter E Haefeli
Impact of serum creatinine measurement error on dose adjustment in renal failure.
Clinical pharmacology and therapeutics 2003;74(5):458-67.
2003: Johanna Weiss; Christian Johannes Kerpen; Heike Lindenmaier; Sven-Maria Gregor Dormann; Walter E Haefeli
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
The Journal of pharmacology and experimental therapeutics 2003;307(1):262-7.
2003: Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
British journal of clinical pharmacology 2003;56(1):32-8.
2003: Yorki Tayrouz; Reinhard Ding; Jürgen Burhenne; Klaus-Dieter Riedel; Johanna Weiss; Torsten Hoppe-Tichy; Walter E Haefeli; Gerd Mikus
Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.
Clinical pharmacology and therapeutics 2003;73(5):397-405.
2003: Johanna Weiss; Sven-Maria Gregor Dormann; Meret Martin-Facklam; Christian Johannes Kerpen; Nahal Ketabi-Kiyanvash; Walter E Haefeli
Inhibition of P-glycoprotein by newer antidepressants.
The Journal of pharmacology and experimental therapeutics 2003;305(1):197-204.
2003: Johanna Weiss; Christiane Hesse; Walter E Haefeli
Rapid and reliable genotyping of the C181T polymorphism in the bradykinin B2 receptor gene.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(3):281-3.
2003: Jürgen Burhenne; Klaus-Dieter Riedel; Meret Martin-Facklam; Gerd Mikus; Walter E Haefeli
Highly sensitive determination of saquinavir in biological samples using liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;784(2):233-42.
2003: Fatima Vrtic; Walter E Haefeli; juergen Drewe; Stephan Krähenbühl; Markus Wenk
Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug.
British journal of clinical pharmacology 2003;55(2):191-8.
2003: Johanna Weiss; Walter E Haefeli; Christiane Gasse; Michael M Hoffmann; Jörn Weyman; Simon Gibbs; Ulrich Mansmann; Peter Bärtsch
Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway.
High altitude medicine & biology 2003;4(3):355-66.
2002: Meret Martin-Facklam; Michael Kostrzewa; Falk Schubert; Christiane Gasse; Walter E Haefeli
Quality markers of drug information on the Internet: an evaluation of sites about St. John's wort.
The American journal of medicine 2002;113(9):740-5.
2002: Meret Martin-Facklam; Jürgen Burhenne; Reinhard Ding; Ruth Fricker; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.
British journal of clinical pharmacology 2002;53(6):576-81.
2002: Johanna Weiss; Ruth Fricker; Walter E Haefeli
Rapid detection of polymorphisms of the nitric oxide cascade.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2002;40(4):341-4.
2002: Ingeborg Walter-Sack; Walter E Haefeli
[Framework for biomedical research involving human subjects - algorithms for planning and organisation].
Deutsche medizinische Wochenschrift (1946) 2002;127(12):627-33.
2002: Johanna Weiss; Jürgen Burhenne; Klaus-Dieter Riedel; Walter E Haefeli
Poor solubility limiting significance of in-vitro studies with HIV protease inhibitors.
AIDS (London, England) 2002;16(4):674-6.
2001: B Khanlari; Lilly Linder; Walter E Haefeli
Local effect of transdermal isosorbide dinitrate ointment on hand vein diameter.
European journal of clinical pharmacology 2001;57(10):701-4.
2001: Yorki Tayrouz; Beate Ganssmann; Reinhard Ding; A Klingmann; Rolf Aderjan; Jürgen Burhenne; Walter E Haefeli; Gerd Mikus
Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement.
Clinical pharmacology and therapeutics 2001;70(5):405-14.
2001: A D Falconnier; Walter E Haefeli; Ronald A Schoenenberger; Christian Surber; M Martin-Facklam
Drug dosage in patients with renal failure optimized by immediate concurrent feedback.
Journal of general internal medicine 2001;16(6):369-75.
2000: Silvana C Romerio; Lilly Linder; J Flammer; Walter E Haefeli
Correlation between apolipoprotein B and endothelin-1-induced vasoconstriction in humans.
Peptides 2000;21(6):871-4.
2000: Meret Martin-Facklam; juergen Drewe; Walter E Haefeli
[Drug interactions with the cytochrome P-450 system].
Deutsche medizinische Wochenschrift (1946) 2000;125(3):63-7.
2000: I Arnet; Walter E Haefeli
Overconsumption detected by electronic drug monitoring requires subtle interpretation.
Clinical pharmacology and therapeutics 2000;67(1):44-7.
1999: Silvana C Romerio; Lilly Linder; Walter E Haefeli
Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilation.
Clinical pharmacology and therapeutics 1999;66(5):522-7.
1999: Anke Ronsdorf; Raymond G Schlienger; Walter E Haefeli; M Martin-Facklam; Ronald A Schoenenberger
[Anticonvulsant hypersensitivity syndrome. 2 case reports and an overview].
Praxis 1999;88(41):1660-6.
1999: Raymond G Schlienger; T F Lüscher; Ronald A Schoenenberger; Walter E Haefeli
Academic detailing improves identification and reporting of adverse drug events.
Pharmacy world & science : PWS 1999;21(3):110-5.
1999: A E Rätz; Raymond G Schlienger; Lilly Linder; Wolf Langewitz; Walter E Haefeli
Pharmacokinetics and pharmacodynamics of clomethiazole after oral and rectal administration in healthy subjects.
Clinical therapeutics 1999;21(5):829-40.
1999: P Fuchs; Walter E Haefeli; H R Ledermann; M Wenk
Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
European journal of clinical pharmacology 1999;54(11):869-76.
1998: J P Rothen; Walter E Haefeli; U A Meyer; Liliane Todesco; Markus Wenk
Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo.
Pharmacogenetics 1998;8(6):553-9.
1998: L V Schuerch; Lilly Linder; E Grouzmann; Walter E Haefeli
Human neuropeptide Y potentiates alpha1-adrenergic blood pressure responses in vivo.
The American journal of physiology 1998;275(3 Pt 2):H760-6.
1998: G R Kaufmann; S Vozeh; M Wenk; Walter E Haefeli
Safety and efficacy of a two-compartment Bayesian feedback program for therapeutic tobramycin monitoring in the daily clinical use and comparison with a non-Bayesian one-compartment model.
Therapeutic drug monitoring 1998;20(2):172-80.
1997: A Gass; Josef Flammer; Lilly Linder; Silvana C Romerio; Patrick Gasser; Walter E Haefeli
Inverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patients.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1997;235(10):634-8.
1997: Walter E Haefeli; Lilly Linder; T F Lüscher
Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
Hypertension 1997;30(4):912-7.
1996: W M Strobel; T F Lüscher; D Simper; L Linder; Walter E Haefeli
Substance P in human hand veins in vivo: tolerance, efficacy, potency, and mechanism of venodilator action.
Clinical pharmacology and therapeutics 1996;60(4):435-43.
1996: G R Kaufmann; M Wenk; W Taeschner; B Peterli; K Gyr; U A Meyer; Walter E Haefeli
N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus.
Clinical pharmacology and therapeutics 1996;60(1):62-7.
1996: Raymond G Schlienger; T F Lüscher; Walter E Haefeli
Clinical pharmacists' effects on drug information requests.
The Annals of pharmacotherapy 1996;30(1):86-7.
1995: D Simper; W M Strobel; L Linder; Walter E Haefeli
Indirect evidence for stimulation of nitric oxide release by tumour necrosis factor-alpha in human veins in vivo.
Cardiovascular research 1995;30(6):960-4.
1995: P Peduzzi; D Simper; L Linder; W M Strobel; Walter E Haefeli
Neuropeptide Y in human hand veins: pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivo.
Clinical pharmacology and therapeutics 1995;58(6):675-83.
1993: Ronald A Schoenenberger; Walter E Haefeli; P Weiss; R Ritz
Evaluation of conventional chest tube therapy for iatrogenic pneumothorax.
Chest 1993;104(6):1770-2.
1993: Walter E Haefeli; Ronald A Schoenenberger; P Weiss; R Ritz
Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose.
The American journal of medicine 1993;94(2):212-5.
1992: Walter E Haefeli; Ronald A Schoenenberger; P Weiss; R Ritz
Possible risk for cardiac arrhythmia related to intravenous erythromycin.
Intensive care medicine 1992;18(8):469-73.
1991: Ronald A Schoenenberger; Walter E Haefeli; P Weiss; R Ritz
Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothorax.
Archives of surgery (Chicago, Ill. : 1960) 1991;126(6):764-6.
1991: Walter E Haefeli; S Vozeh; Huy Riem Ha; W Taeschner; Ferenc Follath
Concentration-effect relations of 5-hydroxypropafenone in normal subjects.
The American journal of cardiology 1991;67(11):1022-6.
1991: Walter E Haefeli; Ronald A Schoenenberger; A Scholer
Recurrent ventricular fibrillation in mianserin intoxication.
BMJ (Clinical research ed.) 1991;302(6773):415-6.
1990: Ronald A Schoenenberger; Walter E Haefeli; P Weiss; R Ritz
Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).
BMJ (Clinical research ed.) 1990;300(6736):1375-6.
1990: S Vozeh; Walter E Haefeli; Huy Riem Ha; J Vlcek; Ferenc Follath
Nonlinear kinetics of propafenone metabolites in healthy man.
European journal of clinical pharmacology 1990;38(5):509-13.